Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Inhaled Nitric Oxide Market by Type (99.92% Purity, 99.99% Purity, Other), By Application (ARDS, PPHN, Other Diseases) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Inhaled Nitric Oxide Market by Type (99.92% Purity, 99.99% Purity, Other), By Application (ARDS, PPHN, Other Diseases) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133678 3300 Pharma & Healthcare 377 233 Pages 4.9 (35)
                                          

The global inhaled nitric oxide market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of respiratory diseases such as ARDS and PPHN diseases, which are treated with inhaled nitric oxide therapy. In addition, the increasing number of patients suffering from chronic obstructive pulmonary disease (COPD) is also driving the growth of this market. The global inhaled nitric oxide market has been segmented on the basis of type, application and region. On the basis of type, it has been segmented into 99.92% purity and 99.99% purity; on the basis of application it has been segmented into ARDS and PPHN diseases; on the basis of region it has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa regions.

  1. Increasing prevalence of respiratory diseases such as asthma and COPD is driving the growth of the global Inhaled Nitric Oxide market.
  2. Increasing awareness about the benefits of inhaled nitric oxide therapy for respiratory diseases such as asthma and COPD is also driving the growth of this market.
  3. The increasing number of patients with chronic obstructive pulmonary disease (COPD) in developing countries such as China, India, and Brazil are also driving this market's growth.
  4. The increasing number of hospitals in developing countries that offer inhaled nitric oxide therapy for respiratory diseases are also contributing to this market's growth.

Industry Growth Insights published a new data on “Inhaled Nitric Oxide Market”. The research report is titled “Inhaled Nitric Oxide Market research by Types (99.92% Purity, 99.99% Purity, Other), By Applications (ARDS, PPHN, Other Diseases), By Players/Companies Mallinckrodt, Praxair, Air Liquide, ...”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Inhaled Nitric Oxide Market Research Report

By Type

99.92% Purity, 99.99% Purity, Other

By Application

ARDS, PPHN, Other Diseases

By Companies

Mallinckrodt, Praxair, Air Liquide, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Inhaled Nitric Oxide Industry Outlook


Global Inhaled Nitric Oxide Market Report Segments:

The global Inhaled Nitric Oxide market is segmented on the basis of:

Types

99.92% Purity, 99.99% Purity, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

ARDS, PPHN, Other Diseases

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Mallinckrodt
  2. Praxair
  3. Air Liquide
  4. ...

Global Inhaled Nitric Oxide Market Overview


Highlights of The Inhaled Nitric Oxide Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 99.92% Purity
    2. 99.99% Purity
    3. Other
  1. By Application:

    1. ARDS
    2. PPHN
    3. Other Diseases
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Inhaled Nitric Oxide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Inhaled Nitric Oxide Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Inhaled nitric oxide (NO) is a gas that is produced when the body breaks down organic material. It helps to relax blood vessels and improve blood flow.

Some of the major companies in the inhaled nitric oxide market are Mallinckrodt, Praxair, Air Liquide.

The inhaled nitric oxide market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Inhaled Nitric Oxide Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Inhaled Nitric Oxide Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Inhaled Nitric Oxide Market - Supply Chain
   4.5. Global Inhaled Nitric Oxide Market Forecast
      4.5.1. Inhaled Nitric Oxide Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Inhaled Nitric Oxide Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Inhaled Nitric Oxide Market Absolute $ Opportunity

5. Global Inhaled Nitric Oxide Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      5.3.1. 99.92% Purity
      5.3.2. 99.99% Purity
      5.3.3. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Inhaled Nitric Oxide Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      6.3.1. ARDS
      6.3.2. PPHN
      6.3.3. Other Diseases
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Inhaled Nitric Oxide Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Inhaled Nitric Oxide Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Inhaled Nitric Oxide Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Inhaled Nitric Oxide Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Inhaled Nitric Oxide Demand Share Forecast, 2019-2029

9. North America Inhaled Nitric Oxide Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Inhaled Nitric Oxide Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      9.4.1. ARDS
      9.4.2. PPHN
      9.4.3. Other Diseases
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      9.7.1. 99.92% Purity
      9.7.2. 99.99% Purity
      9.7.3. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Inhaled Nitric Oxide Demand Share Forecast, 2019-2029

10. Latin America Inhaled Nitric Oxide Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Inhaled Nitric Oxide Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      10.4.1. ARDS
      10.4.2. PPHN
      10.4.3. Other Diseases
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      10.7.1. 99.92% Purity
      10.7.2. 99.99% Purity
      10.7.3. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Inhaled Nitric Oxide Demand Share Forecast, 2019-2029

11. Europe Inhaled Nitric Oxide Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Inhaled Nitric Oxide Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      11.4.1. ARDS
      11.4.2. PPHN
      11.4.3. Other Diseases
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      11.7.1. 99.92% Purity
      11.7.2. 99.99% Purity
      11.7.3. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projectins by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Inhaled Nitric Oxide Demand Share, 2019-2029

12. Asia Pacific Inhaled Nitric Oxide Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Inhaled Nitric Oxide Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      12.4.1. ARDS
      12.4.2. PPHN
      12.4.3. Other Diseases
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      12.7.1. 99.92% Purity
      12.7.2. 99.99% Purity
      12.7.3. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Inhaled Nitric Oxide Demand Share, 2019-2029

13. Middle East & Africa Inhaled Nitric Oxide Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Inhaled Nitric Oxide Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Inhaled Nitric Oxide Market Size and Volume Forecast by Application
      13.4.1. ARDS
      13.4.2. PPHN
      13.4.3. Other Diseases
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Inhaled Nitric Oxide Market Size and Volume Forecast by Type
      13.7.1. 99.92% Purity
      13.7.2. 99.99% Purity
      13.7.3. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Inhaled Nitric Oxide Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Inhaled Nitric Oxide Market: Market Share Analysis
   14.2. Inhaled Nitric Oxide Distributors and Customers
   14.3. Inhaled Nitric Oxide Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Mallinckrodt
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Praxair
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Air Liquide
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. ...
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. COMPANY5
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. COMPANY6
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us